Rehabtronics Receives $1.25 Million from Genome BC
Rehabtronics notes the funds will facilitate free 90-day quality improvement trials of Prelivia at qualified healthcare facilities in the United States.
Florida / New York
Rehabtronics notes the funds will facilitate free 90-day quality improvement trials of Prelivia at qualified healthcare facilities in the United States.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330